Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Met expression and sarcoma tumorigenicity

S Rong1, M Jeffers, J H Resau

  • 1ABL-Basic Research Program, National Cancer Institute, Frederick Cancer Research and Development Center, Maryland 21702.

Cancer Research
|November 15, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Zinc finger protein-36 deficiency inhibits osteogenic differentiation of mouse bone marrow-derived mesenchymal stem cells and preosteoblasts by activating the ERK/MAPK pathway].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University·2024
Same author

[An optimized protocol of meniscus cell extraction for single-cell RNA sequencing].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University·2021
Same author

[Application of selective leukocytapheresis in the treatment of intractable immune disease].

Zhonghua yi xue za zhi·2019
Same author

Differential expression of c-Met between primary and metastatic sites in clear-cell renal cell carcinoma and its association with PD-L1 expression.

Oncotarget·2017
Same author

Enlarging plaques and nodules on the face and legs.

Clinical and experimental dermatology·2017
Same author

A rice jacalin-related mannose-binding lectin gene, OsJRL, enhances Escherichia coli viability under high salinity stress and improves salinity tolerance of rice.

Plant biology (Stuttgart, Germany)·2016
Same journal

CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

Cancer research·2026
Same journal

A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies.

Cancer research·2026
Same journal

Editor's Note: Heterodimerization of Insulin-like Growth Factor Receptor/Epidermal Growth Factor Receptor and Induction of Survivin Expression Counteract the Antitumor Action of Erlotinib.

Cancer research·2026
Same journal

Editor's Note: Deguelin Analogue SH-1242 Inhibits Hsp90 Activity and Exerts Potent Anticancer Efficacy with Limited Neurotoxicity.

Cancer research·2026
Same journal

Retraction: Two Functional Epitopes of Pigment Epithelial-Derived Factor Block Angiogenesis and Induce Differentiation in Prostate Cancer.

Cancer research·2026
Same journal

Editor's Note: Chronic Stress Facilitates Lung Tumorigenesis by Promoting Exocytosis of IGF2 in Lung Epithelial Cells.

Cancer research·2026
See all related articles

The Met-HGF/SF signaling pathway, typically paracrine, may drive sarcoma growth through autocrine signaling in human sarcoma cells. This involves high Met receptor expression and reduced ligand levels, contributing to tumor development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • The Met receptor tyrosine kinase and its ligand, HGF/SF, usually function in a paracrine manner.
  • Aberrant autocrine signaling via Met has been observed in mouse fibroblasts, leading to tumor formation.
  • Human sarcoma cells present a unique context for investigating Met-HGF/SF signaling.

Purpose of the Study:

  • To investigate the role of the Met-HGF/SF signaling system in human sarcomas.
  • To determine if autocrine Met signaling contributes to sarcoma tumorigenesis.
  • To analyze Met and HGF/SF expression and activation in human sarcoma cell lines and tumors.

Main Methods:

  • Analysis of Met receptor and HGF/SF ligand expression in human sarcoma cell lines.
  • Assessment of Met receptor activation in these cell lines.

Related Experiment Videos

  • Immunohistochemical staining of human osteosarcomas, chondrosarcomas, and leiomyosarcomas for Met and HGF/SF.

    • Main Results:

    • Human sarcoma cell lines exhibit high levels of activated Met receptor.
    • These cell lines show reduced HGF/SF levels compared to primary fibroblasts.
    • Human sarcoma tumors display intense Met and/or HGF/SF staining and significant tumor cell heterogeneity.
    • Evidence suggests both paracrine and autocrine Met-HGF/SF signaling contribute to tumor progression.

    Conclusions:

    • Human sarcomas may utilize Met-HGF/SF autocrine signaling for tumorigenesis.
    • The findings highlight the potential of targeting the Met pathway in sarcoma treatment.
    • Tumor cell heterogeneity in signaling suggests complex regulatory mechanisms in sarcoma development.